Cargando…
Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments
Both TCRα and TCRβ types of T-cell receptors contribute to antigen recognition. However, some TCRs have chain centricity, which means that either the α-chain or the β-chain dictates the peptide–MHC complex specificity. Most earlier reports investigated the role of well-studied β-chains in antigen re...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690675/ https://www.ncbi.nlm.nih.gov/pubmed/31448049 http://dx.doi.org/10.18632/oncotarget.27093 |
_version_ | 1783443229216079872 |
---|---|
author | Zamkova, Maria Kalinina, Anastasiya Silaeva, Yuliya Persiyantseva, Nadezhda Bruter, Alexandra Deikin, Alexey Khromykh, Ludmila Kazansky, Dmitry |
author_facet | Zamkova, Maria Kalinina, Anastasiya Silaeva, Yuliya Persiyantseva, Nadezhda Bruter, Alexandra Deikin, Alexey Khromykh, Ludmila Kazansky, Dmitry |
author_sort | Zamkova, Maria |
collection | PubMed |
description | Both TCRα and TCRβ types of T-cell receptors contribute to antigen recognition. However, some TCRs have chain centricity, which means that either the α-chain or the β-chain dictates the peptide–MHC complex specificity. Most earlier reports investigated the role of well-studied β-chains in antigen recognition by TCRαβ. In a previous study, we identified TCRs specific to the H-2K(b) molecule. In the present work, we generated transgenic mice carrying the α-chain of this TCR. We found that these transgenic mice rejected EL-4 tumor cells bearing alloantigen H-2K(b) more effectively than wild-type mice and similarly to mice with established specific memory T cells. Moreover, we found that T cells transduced with this TCRα can inhibit EL-4 cell growth in vitro and in vivo. We also found that transgenic mice recruit fewer CD8 T cells into the peritoneal cavity at the peak of the immune response and had a significantly higher number of central memory CD8 T cells in the spleen of intact transgenic mice compared to intact wild-type control. These results indicate the ability of a single transgenic α-chain of the H-2K(b)-specific TCR to determine specific recognition of the H-2K(b) molecule by a repertoire of T lymphocytes and to rapidly reject H-2K(b)-bearing lymphoma cells. |
format | Online Article Text |
id | pubmed-6690675 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Impact Journals LLC |
record_format | MEDLINE/PubMed |
spelling | pubmed-66906752019-08-23 Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments Zamkova, Maria Kalinina, Anastasiya Silaeva, Yuliya Persiyantseva, Nadezhda Bruter, Alexandra Deikin, Alexey Khromykh, Ludmila Kazansky, Dmitry Oncotarget Research Paper Both TCRα and TCRβ types of T-cell receptors contribute to antigen recognition. However, some TCRs have chain centricity, which means that either the α-chain or the β-chain dictates the peptide–MHC complex specificity. Most earlier reports investigated the role of well-studied β-chains in antigen recognition by TCRαβ. In a previous study, we identified TCRs specific to the H-2K(b) molecule. In the present work, we generated transgenic mice carrying the α-chain of this TCR. We found that these transgenic mice rejected EL-4 tumor cells bearing alloantigen H-2K(b) more effectively than wild-type mice and similarly to mice with established specific memory T cells. Moreover, we found that T cells transduced with this TCRα can inhibit EL-4 cell growth in vitro and in vivo. We also found that transgenic mice recruit fewer CD8 T cells into the peritoneal cavity at the peak of the immune response and had a significantly higher number of central memory CD8 T cells in the spleen of intact transgenic mice compared to intact wild-type control. These results indicate the ability of a single transgenic α-chain of the H-2K(b)-specific TCR to determine specific recognition of the H-2K(b) molecule by a repertoire of T lymphocytes and to rapidly reject H-2K(b)-bearing lymphoma cells. Impact Journals LLC 2019-08-06 /pmc/articles/PMC6690675/ /pubmed/31448049 http://dx.doi.org/10.18632/oncotarget.27093 Text en Copyright: © 2019 Zamkova et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) 3.0 (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Zamkova, Maria Kalinina, Anastasiya Silaeva, Yuliya Persiyantseva, Nadezhda Bruter, Alexandra Deikin, Alexey Khromykh, Ludmila Kazansky, Dmitry Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments |
title | Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments |
title_full | Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments |
title_fullStr | Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments |
title_full_unstemmed | Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments |
title_short | Dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in TCRα transgenic mice and in in vitro experiments |
title_sort | dominant role of the α-chain in rejection of tumor cells bearing a specific alloantigen in tcrα transgenic mice and in in vitro experiments |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690675/ https://www.ncbi.nlm.nih.gov/pubmed/31448049 http://dx.doi.org/10.18632/oncotarget.27093 |
work_keys_str_mv | AT zamkovamaria dominantroleoftheachaininrejectionoftumorcellsbearingaspecificalloantigenintcratransgenicmiceandininvitroexperiments AT kalininaanastasiya dominantroleoftheachaininrejectionoftumorcellsbearingaspecificalloantigenintcratransgenicmiceandininvitroexperiments AT silaevayuliya dominantroleoftheachaininrejectionoftumorcellsbearingaspecificalloantigenintcratransgenicmiceandininvitroexperiments AT persiyantsevanadezhda dominantroleoftheachaininrejectionoftumorcellsbearingaspecificalloantigenintcratransgenicmiceandininvitroexperiments AT bruteralexandra dominantroleoftheachaininrejectionoftumorcellsbearingaspecificalloantigenintcratransgenicmiceandininvitroexperiments AT deikinalexey dominantroleoftheachaininrejectionoftumorcellsbearingaspecificalloantigenintcratransgenicmiceandininvitroexperiments AT khromykhludmila dominantroleoftheachaininrejectionoftumorcellsbearingaspecificalloantigenintcratransgenicmiceandininvitroexperiments AT kazanskydmitry dominantroleoftheachaininrejectionoftumorcellsbearingaspecificalloantigenintcratransgenicmiceandininvitroexperiments |